<DOC>
	<DOCNO>NCT01155999</DOCNO>
	<brief_summary>Efficacy/Safety T1225 , comparison reference product , treatment purulent bacterial conjunctivitis child .</brief_summary>
	<brief_title>Clinical Efficacy Safety T1225 Versus Tobramycin 0.3 % Eye Drops Treatment Purulent Bacterial Conjunctivitis Children .</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Bacterial</mesh_term>
	<mesh_term>Tobramycin</mesh_term>
	<criteria>Age ≥ one day life ≤ 18 year Purulent bacterial conjunctivitis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>